Treating metastatic soft-tissue or bone sarcomas &ndash; potential role of ridaforolimus

Treating metastatic soft-tissue or bone sarcomas &ndash; potential role of ridaforolimus

Vicki L KeedyVanderbilt University Medical Center, Nashville, TN, USAAbstract: Sarcomas of soft tissue and bone are a rare group of cancers hallmarked by relative insensitivity to cytotoxic chemotherapy. The development of targeted therapies in the treatment of sarcoma has been difficult due to the...

Full description

Bibliographic Details
Main Author:	Keedy VL
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-08-01
Series:	OncoTargets and Therapy
Online Access:	http://www.dovepress.com/treating-metastatic-soft-tissue-or-bone-sarcomas-ndash-potential-role--a10777

Similar Items

Recent Advances in the Treatment of Metastatic Soft Tissue Sarcoma
by: Elizabeth J. Davis, et al.
Published: (2018-12-01)

Bone and Soft Tissue Sarcoma
by: Antonio Ruggiero
Published: (2020-09-01)

Soft Tissue and Bone Sarcoma
Published: (2014)

Treatment Strategies for Metastatic Soft Tissue Sarcomas
by: Lisette M. Wiltink, et al.
Published: (2021-04-01)

Bone tumor and soft tissue sarcomas
by: Reynaldo Jesus Garcia Filho
Published: (2008-03-01)

Immunotherapy for Bone and Soft Tissue Sarcomas
by: Takenori Uehara, et al.
Published: (2015-01-01)

Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
by: EL Simpson, et al.
Published: (2010-05-01)

Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat
by: Marcus Laird Forrest, et al.
Published: (2012-12-01)

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
by: Moroncini G, et al.
Published: (2018-02-01)

Bone versus Soft-Tissue Sarcomas in the Elderly
by: Tomoaki Torigoe, et al.
Published: (2010-04-01)

Therapeutic Targets for Bone and Soft-Tissue Sarcomas
by: Shinji Miwa, et al.
Published: (2019-01-01)

Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung
by: Nakamura T, et al.
Published: (2017-01-01)

MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics
by: Subbaya eSubramanian, et al.
Published: (2015-06-01)

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
by: Varun Monga, et al.
Published: (2020-07-01)

Novel Therapeutic Considerations in Bone and Soft Tissue Sarcoma
Published: (2023)

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas. The Experience of the EORTC Soft Tissue and Bone Sarcoma Group
by: Ole S. Nielsen, et al.
Published: (2000-01-01)

Synovial sarcoma of bone: Sarcoma typically of soft tissues presenting as a primary bone tumor
by: Jamie T. Caracciolo, MD, MBA, et al.
Published: (2019-02-01)

Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers
by: Hye Sook Chon, et al.
Published: (2017-06-01)

Long-Term Neurotoxicity of Chemotherapy in Adolescents and Young Adults Treated for Bone and Soft Tissue Sarcomas
by: Helena M. Earl, et al.
Published: (1998-01-01)

Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study
by: Peter Reichardt, et al.
Published: (2012-01-01)

Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin
by: Gianmaria Miolo, et al.
Published: (2020-07-01)

High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy
by: Bruening Thomas, et al.
Published: (2006-06-01)

Head and neck soft tissue sarcomas treated with radiation therapy
by: Lucas K. Vitzthum, et al.
Published: (2016-06-01)

Should Soft Tissue Sarcomas be Treated at a Specialist Centre?
by: A. A. Bhangu, et al.
Published: (2004-01-01)

Definitive Local Therapy Is Associated with Improved Survival in Metastatic Soft Tissue Sarcomas
by: Vishruth K. Reddy, et al.
Published: (2021-02-01)

The Circulating Nucleic Acid Characteristics of Non-Metastatic Soft Tissue Sarcoma Patients
by: Nicholas Eastley, et al.
Published: (2020-06-01)

Very long‐term survivors among patients with metastatic soft tissue sarcoma
by: Mélodie Carbonnaux, et al.
Published: (2019-04-01)

Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations
by: Gino K. In, et al.
Published: (2017-08-01)

Trabectedin for Metastatic Soft Tissue Sarcoma: A Retrospective Single Center Analysis
by: Anthony D. Ho, et al.
Published: (2010-10-01)

Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas
by: Jun Wang, et al.
Published: (2021-01-01)

A quest for therapeutic antigens in bone and soft tissue sarcoma
by: Torigoe Toshihiko, et al.
Published: (2005-08-01)

Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
by: Kenji Nakano, et al.
Published: (2018-03-01)

The Role of Irradiation in the Management of Locally Recurrent Non-Metastatic Soft Tissue Sarcoma of Extremity/Trunkal Locations
by: James Fontanesi, et al.
Published: (2004-01-01)

Role of trabectedin in the treatment of soft tissue sarcoma
by: Alexandre Christinat, et al.
Published: (2009-05-01)

Trabectedin and its potential in the treatment of soft tissue sarcoma
by: Philippe A Cassier, et al.
Published: (2008-03-01)

Olaratumab and doxorubicin for the treatment of metastatic soft tissue sarcoma: a retrospective case series
by: Joon Young Hur, et al.
Published: (2019-06-01)

Anaplastic transformation of metastatic papillary thyroid carcinoma at shoulder mimicking soft tissue sarcoma
by: Seema Kaushal, et al.
Published: (2011-01-01)

Pediatric Soft Tissue and Bone Sarcomas in Tanzania: Epidemiology and Clinical Features
by: E. Mithe Siwillis, et al.
Published: (2019-03-01)

The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework
by: Siegel GW, et al.
Published: (2015-02-01)

The Effectiveness of “Two-Week” Referrals for Suspected Bone and Soft Tissue Sarcoma
by: A. Malik, et al.
Published: (2007-01-01)